Bonifacio-Mundaca, J.; Casavilca-Zambrano, S.; Desterke, C.; Casafont, Í.; Mata-Garrido, J.
Deciphering Medulloblastoma: Epigenetic and Metabolic Changes Driving Tumorigenesis and Treatment Outcomes. Biomedicines 2025, 13, 1898.
https://doi.org/10.3390/biomedicines13081898
AMA Style
Bonifacio-Mundaca J, Casavilca-Zambrano S, Desterke C, Casafont Í, Mata-Garrido J.
Deciphering Medulloblastoma: Epigenetic and Metabolic Changes Driving Tumorigenesis and Treatment Outcomes. Biomedicines. 2025; 13(8):1898.
https://doi.org/10.3390/biomedicines13081898
Chicago/Turabian Style
Bonifacio-Mundaca, Jenny, Sandro Casavilca-Zambrano, Christophe Desterke, Íñigo Casafont, and Jorge Mata-Garrido.
2025. "Deciphering Medulloblastoma: Epigenetic and Metabolic Changes Driving Tumorigenesis and Treatment Outcomes" Biomedicines 13, no. 8: 1898.
https://doi.org/10.3390/biomedicines13081898
APA Style
Bonifacio-Mundaca, J., Casavilca-Zambrano, S., Desterke, C., Casafont, Í., & Mata-Garrido, J.
(2025). Deciphering Medulloblastoma: Epigenetic and Metabolic Changes Driving Tumorigenesis and Treatment Outcomes. Biomedicines, 13(8), 1898.
https://doi.org/10.3390/biomedicines13081898